- How many people are initially infected with resistant virus?
- Transmission of drug-resistant HIV in resource-limited settings
- Factors in transmission of drug-resistant HIV
- Infectiousness and persistence of drug-resistant virus
- Implications for prognosis
- The "New York Case"
- Superinfection[ix]
- Resistance in genital fluids and other bodily tissues
Resistance in genital fluids and other bodily tissues
HIV can be found in blood plasma, peripheral blood mononuclear cells (PBMCs), bodily fluids and human tissue. Most discussions refer to HIV that exists in the blood plasma and PBMCs. However, viral populations in other bodily tissues (compartments) may serve as reservoirs of resistant virus, and sexual transmission depends on virus in the semen and vaginal tissues.
Antiretroviral drugs themselves reach different concentrations in different bodily compartments: AZT and 3TC have been found at higher concentrations in semen than in blood [1], while PIs do not always appear to reach adequate concentrations in semen [2].
A small number of studies have looked for drug-resistant HIV in different tissue compartments. In people treated during the era of single and two-drug therapy, a mixture of wild-type and resistant virus can often by isolated from various cellular reservoirs even after successful suppression of HIV with triple drug therapy [3] [4].
High similarity has been found between resistance profiles in the blood and in the gut tissue. In cases where blood contained 100% mutant virus, gut tissue showed a mix of mutant and wild-type virus [5].
Another study found that HIV variants in the blood plasma and the cerebrospinal fluid (CSF), the fluid around the brain, do not differ in untreated people during the early stages of HIV infection. However, differences have been found between resistance patterns in blood plasma and the central nervous system in people with longer-term infection [6][7].
Several studies have found varying resistance patterns in the blood and genital tract in women [8][9][10], and between the blood and semen in men [11][12][13][14].
In addition, two men treated during primary infection had resistant virus in their blood, but undetectable virus in their semen [15].
Another group found that drug-resistant HIV in the vagina was likely to be associated with macrophages, thus increasing the risk of transmission of drug-resistant virus and reported that virus in blood and vaginal cells may have similar rates of evolution towards resistance [16].
latest aidsmap news
- HIV prevalence may decline because the most vulnerable are infected and die first
- Lack of perceived need for HIV treatment associated with poor adherence
- TB doesn't always increase HIV viral load
- New 75mg darunavir tablet approved by FDA for use by HIV-positive children
- Thyroid checks recommended for people with HIV
- Knighthood for head of UK HIV charity
- Gay men often not accessing PEP despite risk of HIV exposure
- Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV
- Internalised homophobia leads to sexual risk taking by HIV-positive gay men
- Most gay men willing to consider PrEP for possible HIV exposure
